GSK3B and hepatocellular carcinoma: The in vitro data revealed that APs primarily inhibited the Wnt/β-catenin signaling pathway by downregulating β-catenin and p-GSK3β levels while increasing p-β-catenin levels, thereby inhibiting HCC malignancy.